Diet Supplementation with Fish-Derived Extracts Suppresses Diabetes and Modulates Intestinal Microbiome in a Murine Model of Diet-Induced Obesity

Mar Drugs. 2021 May 11;19(5):268. doi: 10.3390/md19050268.

Abstract

Metabolic syndrome-related diseases affect millions of people worldwide. It is well established that changes in nutritional habits and lifestyle can improve or prevent metabolic-related pathologies such as type-2 diabetes and obesity. Previous reports have shown that nutritional supplements have the capacity to limit glucose intolerance and suppress diabetes development. In this study, we investigated the effect of dietary supplementation with fish-derived extracts on obesity and type 2 diabetes and their impact on gut microbial composition. We showed that nutritional supplements containing Fish Complex (FC), Fish Complex combined with Cod Powder (FC + CP), or Cod Powder combined with Collagen (CP + C) improved glucose intolerance, independent of abdominal fat accumulation, in a mouse model of diet-induced obesity and type 2 diabetes. In addition, collagen-containing supplements distinctly modulate the gut microbiome in high-fat induced obesity in mice. Our results suggest that fish-derived supplements suppress diet-induced type 2 diabetes, which may be partly mediated through changes in the gut microbiome. Thus, fish-derived supplements and particularly the ones containing fish collagen have potential beneficial properties as dietary supplements in managing type 2 diabetes and metabolic syndrome via modulation of the gut microbiome.

Keywords: collagen; fish extract; gut microbiome; insulin resistance; obesity; type 2 diabetes.

MeSH terms

  • Abdominal Fat / drug effects
  • Animals
  • Body Weight / drug effects
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diet, High-Fat / adverse effects
  • Dietary Supplements* / microbiology
  • Disease Models, Animal
  • Female
  • Fishes*
  • Gastrointestinal Microbiome / drug effects*
  • Glucose Intolerance / drug therapy
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance
  • Leptin / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Obesity* / chemically induced
  • Obesity* / complications
  • Tissue Extracts / isolation & purification
  • Tissue Extracts / pharmacology*
  • Tissue Extracts / therapeutic use

Substances

  • Hypoglycemic Agents
  • Leptin
  • Tissue Extracts